Horm Metab Res 2015; 47(11): 839-845
DOI: 10.1055/s-0035-1559767
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

Prevalence of Metabolically Healthy Obese and Metabolically Obese but Normal Weight in Adults Worldwide: A Meta-Analysis

B. Wang*
1   Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, P. R. China
2   Department of Preventive Medicine, Shenzhen University School of Medicine, Shenzhen, P. R. China
,
R. Zhuang*
3   School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, P. R. China
4   Shenzhen Health Education and Promotion Center, Shenzhen, P. R. China
,
X. Luo
2   Department of Preventive Medicine, Shenzhen University School of Medicine, Shenzhen, P. R. China
,
L. Yin
5   Department of Prevention and Health Care, Military Hospital of Henan Province, Zhengzhou, P. R. China
,
C. Pang
5   Department of Prevention and Health Care, Military Hospital of Henan Province, Zhengzhou, P. R. China
,
T. Feng
5   Department of Prevention and Health Care, Military Hospital of Henan Province, Zhengzhou, P. R. China
,
H. You
6   Department of Blood Transfusion, Xijing Hospital, The Fourth Military Medical University, Xian, P. R. China
,
Y. Zhai
7   Department of Public Health Surveillance and Advisory, Zhejiang Provincial Centre for Disease Control and Prevention, Hangzhou, P. R. China
,
Y. Ren
1   Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, P. R. China
2   Department of Preventive Medicine, Shenzhen University School of Medicine, Shenzhen, P. R. China
,
L. Zhang
1   Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, P. R. China
2   Department of Preventive Medicine, Shenzhen University School of Medicine, Shenzhen, P. R. China
,
L. Li
1   Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, P. R. China
,
J. Zhao
5   Department of Prevention and Health Care, Military Hospital of Henan Province, Zhengzhou, P. R. China
,
D. Hu
2   Department of Preventive Medicine, Shenzhen University School of Medicine, Shenzhen, P. R. China
› Author Affiliations
Further Information

Publication History

received 27 August 2014

accepted after second revision 28 July 2015

Publication Date:
04 September 2015 (online)

Abstract

The objective of the present study was to summarize the prevalence and influencing factors of metabolically healthy obese (MHO) and metabolically obese but normal weight (MONW) among people≥18 years old in the general population worldwide. We searched for studies of the prevalence of MHO and MONW published in English and Chinese up to October 2013. Pooled prevalence estimates were calculated by a random-effects model according to a Q test. The effects of gender, region, age, sample size, smoking, and alcohol consumption on MHO and MONW were analyzed. Differences between subgroups were assessed by chi-square test. Publication bias was estimated by Egger’s test. Studies of MHO and MONW showed heterogeneity (I2=99.4% and I2=99.7%, respectively). The overall prevalence of MHO and MONW was 7.27% (95% CI 5.92–8.90%) and 19.98% (95% CI 16.54–23.94%), respectively. American populations had the highest MHO prevalence and European populations the highest MONW prevalence. Different patterns of MHO and MONW were observed in the subgroup analysis with respect to gender, age, sample size, smoking, alcohol consumption, and metabolically healthy criteria. The prevalence of both MHO and MONW were affected by gender, region, age, sample size, smoking, alcohol consumption, and metabolically healthy criteria, but studies showed high heterogeneity.

* B. Wang and R. Zhuang contributed equally to this work.


Supporting Information

 
  • References

  • 1 Denis GV, Obin MS. ‛Metabolically healthy obesity’: origins and implications. Mol Aspects Med 2013; 34: 59-70
  • 2 Kwon BJ, Kim DW, Her SH, Kim DB, Jang SW, Cho EJ, Ihm SH, Kim HY, Youn HJ, Seung KB, Kim JH, Rho TH. Metabolically obese status with normal weight is associated with both the prevalence and severity of angiographic coronary artery disease. Metabolism 2013; 62: 952-960
  • 3 Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know?. J Clin Endocrinol Metab 2004; 89: 2569-2575
  • 4 Ogorodnikova AD, Kim M, McGinn AP, Muntner P, Khan U, Wildman RP. Incident cardiovascular disease events in metabolically benign obese individuals. Obesity (Silver Spring) 2012; 20: 651-659
  • 5 Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW, Adams RJ. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 2013; 36: 2388-2394
  • 6 Hosseinpanah F, Barzin M, Sheikholeslami F, Azizi F. Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS). Am J Cardiol 2011; 107: 412-416
  • 7 Conus F, Rabasa-Lhoret R, Peronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 2007; 32: 4-12
  • 8 Lopez-Miranda J, Perez-Martinez P. It is time to define metabolically obese but normal-weight (MONW) individuals. Clin Endocrinol (Oxf) 2013; 79: 314-315
  • 9 Ruderman NB, Schneider SH, Berchtold P. The “metabolically-obese,” normal-weight individual. Am J Clin Nutr 1981; 34: 1617-1621
  • 10 Ruderman NB, Berchtold P, Schneider S. Obesity-associated disorders in normal-weight individuals: some speculations. Int J Obes 1982; 6 (Suppl. 01) 151-157
  • 11 Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998; 47: 699-713
  • 12 Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D’Agostino RB. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906-2912
  • 13 Bradshaw PT, Monda KL, Stevens J. Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the Atherosclerosis Risk in Communities Study. Obesity (Silver Spring) 2013; 21: 203-209
  • 14 Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V, Sladek R, Rabasa-Lhoret R. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011; 35: 971-981
  • 15 Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, Villa M, Mannino S, Crosignani P, Bosi E, Luzi L, Ruotolo G, Perseghin G. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011; 34: 210-215
  • 16 Song Y, Manson JE, Meigs JB, Ridker PM, Buring JE, Liu S. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol 2007; 100: 1654-1658
  • 17 Pataky Z, Bobbioni-Harsch E, Golay A. Open questions about metabolically normal obesity. Int J Obes (Lond) 2010; 34 (Suppl. 02) S18-S23
  • 18 Hamer M, Batty GD, Kivimaki M. Risk of future depression in people who are obese but metabolically healthy: the English longitudinal study of ageing. Mol Psychiatry 2012; 17: 940-945
  • 19 Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012; 97: 2482-2488
  • 20 Lee K. Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors. Asia Pac J Clin Nutr 2009; 18: 280-284
  • 21 Loney PL, Chambers LW, Bennett KJ, Roberts JG, Stratford PW. Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can 1998; 19: 170-176
  • 22 Yang Y, Li X, Zhou F, Jin Q, Gao L. Prevalence of drug-resistant tuberculosis in mainland China: systematic review and meta-analysis. PLoS One 2011; 6: e20343
  • 23 Tadesse G. Prevalence of human Salmonellosis in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis 2014; 14: 88
  • 24 Gao L, Zhang L, Jin Q. Meta-analysis: prevalence of HIV infection and syphilis among MSM in China. Sex Transm Infect 2009; 85: 354-358
  • 25 Phillips CM, Dillon C, Harrington JM, McCarthy VJ, Kearney PM, Fitzgerald AP, Perry IJ. Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS One 2013; 8: e76188
  • 26 Lopez-Garcia E, Guallar-Castillon P, Leon-Munoz L, Rodriguez-Artalejo F. Prevalence and determinants of metabolically healthy obesity in Spain. Atherosclerosis 2013; 231: 152-157
  • 27 Gomez-Huelgas R, Narankiewicz D, Villalobos A, Warnberg J, Mancera-Romero J, Cuesta AL, Tinahones FJ, Bernal-Lopez MR. Prevalence of Metabolically Discordant Phenotypes in a Mediterranean Population-The IMAP Study. Endocr Pract 2013; 19: 758-768
  • 28 Hwang LC, Bai CH, Sun CA, Chen CJ. Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pac J Clin Nutr 2012; 21: 227-233
  • 29 Shea JL, Randell EW, Sun G. The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry. Obesity (Silver Spring) 2011; 19: 624-630
  • 30 Pajunen P, Kotronen A, Korpi-Hyovalti E, Keinanen-Kiukaanniemi S, Oksa H, Niskanen L, Saaristo T, Saltevo JT, Sundvall J, Vanhala M, Uusitupa M, Peltonen M. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Public Health 2011; 11: 754
  • 31 Geetha L, Deepa M, Anjana RM, Mohan V. Prevalence and clinical profile of metabolic obesity and phenotypic obesity in Asian Indians. J Diabetes Sci Technol 2011; 5: 439-446
  • 32 Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P. Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr 2010; 64: 1043-1051
  • 33 Flowers E, Molina C, Mathur A, Reaven GM. Adiposity and Cardiovascular Risk Clustering in South Asians. Metab Syndr Relat Disord 2013; 11: 434-440
  • 34 Choi KM, Cho HJ, Choi HY, Yang SJ, Yoo HJ, Seo JA, Kim SG, Baik SH, Choi DS, Kim NH. Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans. Clin Endocrinol (Oxf) 2013; 79: 364-370
  • 35 Lee SH, Ha HS, Park YJ, Lee JH, Yim HW, Yoon KH, Kang MI, Lee WC, Son HY, Park YM, Kwon HS. Identifying metabolically obese but normal-weight (MONW) individuals in a nondiabetic Korean population: the Chungju Metabolic disease Cohort (CMC) study. Clin Endocrinol (Oxf) 2011; 75: 475-481
  • 36 Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 2008; 168: 1617-1624
  • 37 Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality?. Diabetes Care 2009; 32: 2297-2299
  • 38 Aguilar-Salinas CA, Garcia EG, Robles L, Riano D, Ruiz-Gomez DG, Garcia-Ulloa AC, Melgarejo MA, Zamora M, Guillen-Pineda LE, Mehta R, Canizales-Quinteros S, Tusie Luna MT, Gomez-Perez FJ. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 2008; 93: 4075-4079
  • 39 Soriguer F, Gutierrez-Repiso C, Rubio-Martin E, Garcia-Fuentes E, Almaraz MC, Colomo N, Esteva de Antonio I, de Adana MS, Chaves FJ, Morcillo S, Valdes S, Rojo-Martinez G. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrinol Metab 2013; 98: 2318-2325
  • 40 Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, Church TS, Blair SN. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013; 34: 389-397
  • 41 Marini MA, Frontoni S, Succurro E, Arturi F, Fiorentino TV, Sciacqua A, Perticone F, Sesti G. Differences in insulin clearance between metabolically healthy and unhealthy obese subjects. Acta Diabetol 2014; 51: 257-261
  • 42 Lee SK, Kim SH, Cho GY, Baik I, Lim HE, Park CG, Lee JB, Kim YH, Lim SY, Kim H, Shin C. Obesity phenotype and incident hypertension: a prospective community-based cohort study. J Hypertens 2013; 31: 145-151
  • 43 Hong HC, Lee JS, Choi HY, Yang SJ, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination Survey. Metabolism 2013; 62: 1305-1312
  • 44 Guerrero-Romero F, Rodriguez-Moran M. Serum magnesium in the metabolically-obese normal-weight and healthy-obese subjects. Eur J Intern Med 2013; 24: 639-643
  • 45 Jing F, Bo Z, Qifu L, Ling W, Zhiho W, Suhua Z, Yi Z, Hua L. Corss-sectional study on distribution and risk factors of special subgroups of obesity in community based-subjects. Shanghai Med J 2011; 34: 345-350
  • 46 Park J, Kim SH, Cho GY, Baik I, Kim NH, Lim HE, Kim EJ, Park CG, Lim SY, Kim YH, Kim H, Lee SK, Shin C. Obesity phenotype and cardiovascular changes. J Hypertens 2011; 29: 1765-1772
  • 47 Hinnouho GM, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?. Diabetes Care 2013; 36: 2294-2300
  • 48 Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med 2013; 159: 758-769
  • 49 Rao UK. Concepts in sample size determination. Indian J Dent Res 2012; 23: 660-664
  • 50 Kilpelainen TO, Zillikens MC, Stancakova A, Finucane FM, Ried JS, Langenberg C, Zhang W, Beckmann JS, Luan J, Vandenput L, Styrkarsdottir U, Zhou Y, Smith AV, Zhao JH, Amin N, Vedantam S, Shin SY, Haritunians T, Fu M, Feitosa MF, Kumari M, Halldorsson BV, Tikkanen E, Mangino M, Hayward C, Song C, Arnold AM, Aulchenko YS, Oostra BA, Campbell H, Cupples LA, Davis KE, Doring A, Eiriksdottir G, Estrada K, Fernandez-Real JM, Garcia M, Gieger C, Glazer NL, Guiducci C, Hofman A, Humphries SE, Isomaa B, Jacobs LC, Jula A, Karasik D, Karlsson MK, Khaw KT, Kim LJ, Kivimaki M, Klopp N, Kuhnel B, Kuusisto J, Liu Y, Ljunggren O, Lorentzon M, Luben RN, McKnight B, Mellstrom D, Mitchell BD, Mooser V, Moreno JM, Mannisto S, O'Connell JR, Pascoe L, Peltonen L, Peral B, Perola M, Psaty BM, Salomaa V, Savage DB, Semple RK, Skaric-Juric T, Sigurdsson G, Song KS, Spector TD, Syvanen AC, Talmud PJ, Thorleifsson G, Thorsteinsdottir U, Uitterlinden AG, van Duijn CM, Vidal-Puig A, Wild SH, Wright AF, Clegg DJ, Schadt E, Wilson JF, Rudan I, Ripatti S, Borecki IB, Shuldiner AR, Ingelsson E, Jansson JO, Kaplan RC, Gudnason V, Harris TB, Groop L, Kiel DP, Rivadeneira F, Walker M, Barroso I, Vollenweider P, Waeber G, Chambers JC, Kooner JS, Soranzo N, Hirschhorn JN, Stefansson K, Wichmann HE, Ohlsson C, O’Rahilly S, Wareham NJ, Speliotes EK, Fox CS, Laakso M, Loos RJ. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet 2011; 43: 753-760